Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
American Cryostem Corp
(OP:
CRYO
)
N/A
UNCHANGED
Last Price
Updated: 3:04 PM EDT, Apr 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about American Cryostem Corp
American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS)
March 04, 2022
EATONTOWN, NJ / ACCESSWIRE / March 4, 2022 / American CryoStem Corporation (OTC PINK:CRYO) a clinical stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and...
From
American CryoStem Corporation
Via
AccessWire
American CryoStem Announces Completion of Patient Recruitment for its Post-Concussion Syndrome (PCS) ATCELL(TM) Phase I Clinical Trial
December 22, 2021
EATONTOWN, NJ / ACCESSWIRE / December 22, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing...
From
American CryoStem Corporation
Via
AccessWire
American CryoStem Completes Clinical Protocol Design for Long COVID Study
November 30, 2021
EATONTOWN, NJ / ACCESSWIRE / November 30, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading clinical-stage biotechnology developer of adipose-derived stem cell therapies today announced...
From
American CryoStem Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
American CryoStem Announces the Addition of John Schwartz, PhD to Its Advisory Board
November 23, 2021
EATONTOWN, NJ / ACCESSWIRE / November 23, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading clinical-stage biotechnology developer of adipose tissue-based cellular technologies for...
From
American CryoStem Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
American CryoStem to Study New Standardized Treatment Protocols for Wound Healing
November 16, 2021
EATONTOWN, NJ / ACCESSWIRE / November 16, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing...
From
American CryoStem Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
American CryoStem Enters into an Agreement to Exchange Shares held by ACS Global, Inc
November 12, 2021
EATONTOWN, NJ / ACCESSWIRE / November 12, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading strategic cellular application developer, global licensor of patented adipose tissue-based...
From
American CryoStem Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
American CryoStem Executes LOI with Advanced Regenerative Associates to Conduct Wound Healing Clinical Study
May 06, 2021
EATONTOWN, NJ / ACCESSWIRE / May 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and...
From
American CryoStem Corporation
Via
AccessWire
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.